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21
Hyperlipidemia starts at a pediatric age and represents an unquestionable risk factor for 22 cardiovascular disease. Modulation of the intestinal microbial ecosystem (IME), in principle, can 23 ameliorate lipid profiles. In this study, we characterized the IME of children and adolescents with 24 primary hyperlipidemia by analyzing fecal samples through 16S rRNA gene profiling (n=15) and 25 short chain fatty acid (SCFA) quantification (n=32). The same analyses were also carried out on 26 age-matched normolipidemic controls (n=15). Moreover, we evaluated the modulatory effect of Roseburia, and Faecalibacterium. This study suggests that children and adolescents with primary 37 hyperlipidemia possess an altered IME. The promising results presented here support the need for 38 future dietary interventions aimed at positively modulating the IME of hyperlipidemic subjects.
Dietary interventions appear to be a promising strategy for managing premature hyperlipidemia.
48
For instance, the intake of a fiber-containing food supplement was shown to reduce total 49 cholesterol, LDL-C levels, and apolipoprotein B in hypercholesterolemic children (Guardamagna et production of conjugated linoleic acid in the gut (Guardamagna et al. 2014 ).
57
In principle, modulation of the gut microbiota could represent an additional strategy for the 58 amelioration of lipid profiles. In fact, expanding scientific evidence indicates that the gut microbiota 59 mediates pathophysiological mechanisms that alter lipid metabolism and other related metabolic 60 traits (Ghazalpour et al. 2016) . Particularly, the intestinal microbiota has been recognized as a 61 metabolically active endocrine organ of the human superorganism that can be a therapeutic target 62 for hyperlipidemia and associated cardiometabolic diseases (Brahe et al. 2016; Ghazalpour et al. 63 2016). In fact, numerous metabolites produced by intestinal bacteria, such as 64 trimethylamine/trimethylamine-N-oxide, secondary bile acids, catecholamines, and short chain fatty 65 acids (SCFAs), are not simply absorbed and metabolized by human cells for energy needs but also 66 act as hormone-like factors that impact numerous aspects of host physiology (Boulange et , the intestinal microbial ecosystem (IME) has never been thoroughly 77 investigated in young people with inherited hyperlipidemia.
78
Hyperlipidemic subjects could receive both specific and overall benefits by consuming dietary considerations, in this study, we characterized the IME of children and adolescents with primary 85 hyperlipidemia by means of 16S rRNA gene profiling and short chain fatty acid (SCFA) 86 quantification in fecal samples. Furthermore, the potential modulatory effects of regular hazelnut 87 intake on microbiota composition and SCFA levels were investigated. Finally, we studied the 88 potential correlations existing between the IME and hyperlipidemia-related clinical parameters. 
Materials and methods
91
Ethics approval and consent to participate. The study protocol conformed with the principles 92 outlined in the Declaration of Helsinki and was approved by the Ethics Committee of the City of
93
Health and Science University Hospital of Turin, Italy (EC:CS377). The protocol and aim of the 94 study were explained in detail to all participants and their legal guardians; before participants were 95 enrolled in the study, their guardians signed an informed consent.
96
Participants. The volunteers considered in the present study were derived from a subgroup of 97 children and adolescents with primary hyperlipidemia; they were aged between 7 and 17 years old Table S1 . 107 The recruited hyperlipidemic subjects were asked to collect a stool sample before and after the 108 intervention. Thirty-two stool samples were collected for analysis at baseline, but only 15 samples 109 were available after eight weeks of hazelnut with skin (HZN+S) consumption. The effect of dietary 110 intervention on the fecal microbiota composition was analyzed in 15 subjects, whereas the levels of 111 SCFAs were evaluated in the whole group of children and adolescents with primary hyperlipidemia 112 who provided stool samples at baseline.
113
To be eligible, screened children and adolescents were required to be of normal weight with a 114 diagnosis of primary hyperlipemia, including familial hypercholesterolemia (FH), familial 115 combined hyperlipidemia (FCHL) or polygenic hypercholesterolemia (PHC), with total serum 116 cholesterol (TC) and/or triglycerides (TG) levels higher than age-and sex-specific 90 th percentiles.
117
The diagnostic criteria of primary hyperlipidemia were based on accepted international standards as 118 previously reported (Guardamagna et al. 2009 weekly food diaries as previously reported (Deon et al. 2017a ).
151
At baseline and at the end of the HZN+S intervention (0 and 8 weeks), each study participant 152 underwent a medical examination after an overnight fast, during which biological samples and 153 physical parameters (including height, weight and blood pressure measurements) were obtained.
154
Serum levels of TC, HDL-C and TG were directly determined by an automatic biochemical 155 analyzer (Olympus AU2700, Japan), whereas the LDL-C concentration was estimated using the
156
Friedewald formula (LDL=TC-(HDL+TG/5)), and non-high density lipoprotein cholesterol (non-157 HDL) was calculated by subtracting HDL-C from TC.
158
The fecal samples were collected from each participant in a sterile plastic pot within 24 h before to deliver the fecal sample to the laboratory within 24 h. Upon delivery, stool samples were stored at
163
-80°C until DNA extraction. Subjects were asked to return any uneaten HZN+S packages at the visit.
164
Compliance was assessed by weighing returned packages and checking weekly food diaries. quantifications were performed as previously described (Gargari et al. 2016 ). In brief, stools (200 ± 187 10 mg) were extracted in 10 ml of 0.001% HCOOH by vortexing for 1 min. The supernatant was 188 then recovered through centrifugation at 1000 x g for 2 min at 4 °C. analysis. Significant differences between groups of samples in β-diversity were assessed through 211 the non-parametric statistical test ANOSIM (analysis of similarities).
212
Differences in SCFA concentrations were evaluated by analyzing the data with a non-parametric
213
Wilcoxon-Mann-Whitney test using paired data (when allowed).
214
The correlation analyses were carried out using Kendall and Spearman formulas with changes 215 over the treatment in bacterial taxa abundances (DESeq2-normalized data), lipidemic profile data 216 and fecal SCFA concentrations in hyperlipidemic subjects.
217
Statistical significance was set at p≤0.05; the mean differences with 0.05<p≤0.10 were accepted 218 as trends. When p value correction was applied, false discovery rate (FDR) adjustment was used. evidenced by the analysis of β-diversity (Fig. 1) .
234
The analysis of β-diversity performed with the unweighted UniFrac algorithm evidenced a 235 significant segregation of controls from hyperlipidemic samples (p<0.05 and number of 236 permutations=99 according to ANOSIM test), which was principally led by the abundance of
237
Faecalibacterium spp. and two unidentified Clostridiales genera (Fig. 1B) . Also, the intrasample
238
(α)-diversity analyzed through the Chao1 index evidenced a difference between hyperlipidemic and 239 control samples (Fig. 2) between the groups when we analyzed α-diversity with the inverse Simpson index, which estimates 243 biodiversity also considering OTU evenness (Fig. 2B) . In addition, microbiota diversity analyses 244 failed to reveal age-related differences in the IME of volunteers (Fig. S1 ).
245
Overall, the taxonomic composition of the fecal microbiota of both hyperlipidemic and control i.e., Lachnospiraceae, Ruminococcaceae, and an undefined family of the order, constituted more 249 than 50% of all bacteria in both hyperlipidemic and control subjects (Fig. S2 ). In addition, the most 
254
To infer taxonomic signatures distinguishing the fecal microbiota structure of the 15 255 hyperlipidemic participants and the 15 aged-matched normolipidemic controls, we performed a 256 comparative analysis at the OTU level through the DESeq negative binomial distribution method.
257
We found 229 OTUs whose abundance was significantly different between the two groups of 258 subjects ( Fig. S3 and Fig. 3 ): 193 OTUs were increased in the controls, whereas only 36 OTUs
259
were increased in the hyperlipidemic samples (Fig. S3) were significantly increased compared to control subjects (Fig. 4) Hazelnut intake induced limited changes in bacterial abundances but modulated SCFA levels 287 in feces. The α-and β-diversity of fecal samples were not significantly affected by the eight-week 288 hazelnut intervention ( Fig. 1 and Fig. 2) . Furthermore, we did not find any OTU that was modified
289
with an FDR adjusted p value (padJ) lower than the significance limit of 0.05 (Fig. S5) . Only an 290 undefined Clostridiales OTU, which was reduced after the intervention, displayed a padJ value 291 lower than 0.1 (Fig. S5 ).
292
Subsequently, we quantified the fecal level of 8 SCFAs and lactate after hazelnut consumption in 293 14 hyperlipidemic subjects that completed the intervention (Fig. 4) 13 of them (7 positively and 6 negatively correlated) were ascribed to the order Clostridiales. In this study, we show for the first time that young individuals with inherited hyperlipidemia may 325 possess a dysbiotic gut bacterial ecosystem. We came to this result by comparing the IME of 326 hyperlipidemic children and adolescents (ages ranging from 7 to 17 years old, mean age of 11) with 327 the IME of age-matched normolipidemic controls (ages ranging from 5 to 17 years old, mean age of 328 11). Although the age range was considered quite wide, spanning from early school-aged childhood
329
to late adolescence, we did not observe age-related differences in the IME of volunteers (Fig. S1 ), to the overall diet were comparable between the two groups of subjects (data not shown).
338
Particularly, fiber intake was at the lower range of CHILD-1 recommendations as previously Isobutyrate, which is produced in the gut by the degradation of amino acids, such as valine (Zarling 411 and Ruchim 1987), has been found to be correlated with behavior changes induced by prebiotics in However, the actual importance of the modification of these organic acids in the human gut is unclear,
415
and the literature is too limited yet to allow a complete interpretation of our results.
416
Although the hazelnut intervention significantly modified the fecal levels of SCFAs, the 
685
This figure only includes OTUs whose change over the hazelnut intervention significantly 686
